Defiance ETFs PSY Company Profile

Defiance ETFs launched PSY, the first U.S market psychedelic ETF to be listed on the NYSE.  This gives investors exposure to companies that are involved with next generation medicine.  Now investors are able to invest in Cybin on the NYSE through PSY.

Click here to see PSY full hodlings.

Investor Presentation

Cannacord Genuity Research Report

Roth Capital Partners - Cybin, Inc Target Price

Roth Capital Partners Research Report